doi:10.16150/j.1671-2870.2021.06.001

Abstract

CLC Number:

R715.2

Figures/Tables 4

References 31

[1]	Barriga F, Ramírez P, Wietstruck A, et al. Hematopoietic stem cell transplantation: clinical use and perspectives[J]. Biol Res, 2012, 45(3):307-316. doi: 10.4067/S0716-97602012000300012 URL
[2]	de la Morena MT, Gatti RA. A history of bone marrow transplantation[J]. Hematol Oncol Clin North Am, 2011, 25(1):1-15. doi: 10.1016/j.hoc.2010.11.001 URL
[3]	Niederwieser D, Baldomero H, Szer J, et al. Hematopoie-tic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey[J]. Bone Marrow Transplant, 2016, 51(6):778-785. doi: 10.1038/bmt.2016.18 URL
[4]	Panoskaltsis-Mortari A, Griese M, Madtes DK, et al. An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome[J]. Am J Respir Crit Care Med, 2011, 183(9):1262-1279. doi: 10.1164/rccm.2007-413ST URL
[5]	Soubani AO, Pandya CM. The spectrum of noninfectious pulmonary complications following hematopoietic stem cell transplantation[J]. Hematol Oncol Stem Cell Ther, 2010, 3(3):143-157. pmid: 20890072
[6]	Fukuda T, Hackman RC, Guthrie KA, et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation[J]. Blood, 2003, 102(8):2777-2785. doi: 10.1182/blood-2003-05-1597 URL
[7]	Cengiz Seval G, Topçuoğlu P, Demirer T. Current approach to non-infectious pulmonary complications of hematopoietic stem cell transplantation[J]. Balkan Med J, 2018, 35(2):131-140. doi: 10.4274/balkanmedj.2017.1635 URL
[8]	Thompson J, Yin Z, D′Souza A, et al. Etanercept and corticosteroid therapy for the treatment of late-onset idiopathic pneumonia syndrome[J]. Biol Blood Marrow Transplant, 2017, 23(11):1955-1960. doi: 10.1016/j.bbmt.2017.07.019 URL
[9]	Cornell RF, Hari P, Drobyski WR. Engraftment syndrome after autologous stem cell transplantation: an update unifying the definition and management approach[J]. Biol Blood Marrow Transplant, 2015, 21(12):2061-2068. doi: 10.1016/j.bbmt.2015.08.030 URL
[10]	Capizzi SA, Kumar S, Huneke NE, et al. Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation[J]. Bone Marrow Transplant, 2001, 27(12):1299-1303. doi: 10.1038/sj.bmt.1703075 URL
[11]	Martínez-Cibrian N, Magnano L, Gutiérrez-García G, et al. At-home autologous stem cell transplantation in multiple myeloma with and without G-CSF administration: a comparative study[J]. Bone Marrow Transplant, 2016, 51(4):593-595. doi: 10.1038/bmt.2015.287 URL
[12]	Bondeelle L, Bergeron A. Managing pulmonary complications in allogeneic hematopoietic stem cell transplantation[J]. Expert Rev Respir Med, 2019, 13(1):105-119. doi: 10.1080/17476348.2019.1557049 URL
[13]	Chi AK, Soubani AO, White AC, et al. An update on pulmonary complications of hematopoietic stem cell transplantation[J]. Chest, 2013, 144(6):1913-1922. doi: 10.1378/chest.12-1708 URL
[14]	Ahya VN. Noninfectious acute lung injury syndromes early after hematopoietic stem cell transplantation[J]. Clin Chest Med, 2017, 38(4):595-606. doi: 10.1016/j.ccm.2017.07.002 URL
[15]	Zhang Z, Wang C, Peters SG, et al. Epidemiology, risk factors, and outcomes of diffuse alveolar hemorrhage after hematopoietic stem cell transplantation[J]. Chest, 2021, 159(6):2325-2333. doi: 10.1016/j.chest.2021.01.008 URL
[16]	Wenger DS, Triplette M, Crothers K, et al. Incidence, risk factors, and outcomes of idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation[J]. Biol Blood Marrow Transplant, 2020, 26(2):413-420. doi: 10.1016/j.bbmt.2019.09.034 URL
[17]	Keklik F, Alrawi EB, Cao Q, et al. Diffuse alveolar hemor-rhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics[J]. Haematologica, 2018, 103(12):2109-2115. doi: 10.3324/haematol.2018.189134 pmid: 30076172
[18]	Haider S, Durairajan N, Soubani AO. Noninfectious pulmonary complications of haematopoietic stem cell transplantation[J]. Eur Respir Rev, 2020, 29(156):190119. doi: 10.1183/16000617.0119-2019 URL
[19]	Nakasone H, Onizuka M, Suzuki N, et al. Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchio-litis obliterans organizing pneumonia after hematopoietic cell transplantation[J]. Bone Marrow Transplant, 2013, 48(10):1317-1323. doi: 10.1038/bmt.2013.116 URL
[20]	Adachi Y, Ozeki K, Ukai S, et al. Patterns of onset and outcome of cryptogenic organizing pneumonia after allogeneic hematopoietic stem cell transplantation[J]. Int J Hematol, 2019, 109(6):700-710. doi: 10.1007/s12185-019-02643-9 URL
[21]	Shiari A, Nassar M, Soubani AO. Major pulmonary complications following hematopoietic stem cell transplantation: What the pulmonologist needs to know[J]. Respir Med, 2021, 185:106493. doi: 10.1016/j.rmed.2021.106493 URL
[22]	Ueda K, Watadani T, Maeda E, et al. Outcome and treatment of late-onset noninfectious pulmonary complications after allogeneic haematopoietic SCT[J]. Bone Marrow Transplant, 2010, 45(12):1719-1727. doi: 10.1038/bmt.2010.48 URL
[23]	Kwok WC, Liang BM, Lui MMS, et al. Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome[J]. Respirology, 2019, 24(5):459-466. doi: 10.1111/resp.13472 URL
[24]	Gazourian L, Rogers AJ, Ibanga R, et al. Factors associa-ted with bronchiolitis obliterans syndrome and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation[J]. Am J Hematol, 2014, 89(4):404-409. doi: 10.1002/ajh.23656 pmid: 24375545
[25]	Williams KM, Cheng GS, Pusic I, et al. Fluticasone, azithromycin, and montelukast treatment for new-onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation[J]. Biol Blood Marrow Transplant, 2016, 22(4):710-716. doi: 10.1016/j.bbmt.2015.10.009 URL
[26]	Williams KM. How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation[J]. Blood, 2017, 129(4):448-455. doi: 10.1182/blood-2016-08-693507 pmid: 27856461
[27]	Astashchanka A, Ryan J, Lin E, et al. Pulmonary Complications in Hematopoietic Stem Cell Transplant Reci-pients-A Clinician Primer[J]. J Clin Med, 2021, 10(15):3227. doi: 10.3390/jcm10153227 URL
[28]	Bondeelle L, Gras J, Michonneau D, et al. Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation[J]. Bone Marrow Transplant, 2020, 55(5):982-986. doi: 10.1038/s41409-019-0636-8 URL
[29]	Sato S, Hanibuchi M, Takahashi M, et al. A patient with idiopathic pleuroparenchymal fibroelastosis showing a sustained pulmonary function due to treatment with pirfenidone[J]. Intern Med, 2016, 55(5):497-501. doi: 10.2169/internalmedicine.55.5047 URL
[30]	Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension[J]. Eur Respir J, 2019, 53(1):1801913. doi: 10.1183/13993003.01913-2018 URL
[31]	Dandoy CE, Hirsch R, Chima R, et al. Pulmonary hypertension after hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant, 2013, 19(11):1546-1556. doi: 10.1016/j.bbmt.2013.07.017 URL

肺实质	血管内皮	气道上皮
急性呼吸窘迫综合征	移植期呼吸窘迫综合征	隐源性机化性肺炎
迟发性肺毒性综合征	弥漫性肺泡出血	闭塞性细支气管炎
急性间质性肺炎

分类	好发时间	危险因素	检查	影像学	临床表现	治疗
PERDS	植入期,多在移植后2周	女性、GM-CSF	HRCT	弥漫性磨玻璃样阴影,胸腔积液	低氧血症伴发热、皮疹	糖皮质激素,预后好
DAH	移植后11~21 d	药物、感染、GVHD	支气管肺泡灌洗	早期磨玻璃样阴影和实变伴空气支气管征, 后期铺路石改变	低氧血症、咯血、咳白痰	针对病因治疗,通气支持及激素,预后差
COP	移植后2~15个月, 中位108 d	女供男、HLA 配型不合、急慢性 GVHD	HRCT及肺功能	肺有实变或斑片影,可伴有磨玻璃样和结节样改变	发热、干咳和呼吸困难	糖皮质激素
BOS	移植后第3个月至2年	移植前低FEV₁/FVC、急或慢性GVHD、无关或女性供体、	HRCT及肺功能	马赛克征、气体闭陷征、外周支气管管壁增厚和扩张	气流阻塞的相关症状	免疫抑制剂,FAM 方案
PPFE	移植后数月至数年	预处理放化疗及 GVHD	HRCT及肺功能	上叶纤维化伴胸膜下及胸膜下增厚伴缩窄、体积缩小及牵引性支气管扩张	干咳、呼吸困难	肺移植
TALS	继发于BOS、COP 及ILD	慢性GVHD、男性、移植时年龄<38岁和使用他克莫司	胸片、CT	气胸	胸痛、呼吸困难	胸腔闭式引流
肺动脉高压	移植后2~6个月	放化疗损伤	超声心动图、右心导管术	右心室增大,肺弥漫性磨玻璃样改变	右心衰症状	类前列腺素、内皮素受体拮抗剂等
PTLD	移植后前6个月	去T细胞移植物、抗胸腺细胞球蛋白使用、 GVHD等	血EB拷贝数、 PET/CT及活检	PET/CT检查出现高代谢病灶	发热、淋巴结肿大及呼吸系统症状	免疫抑制剂减停及利妥昔单抗

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 31

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 425-430.
[2]	. [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(04): 419-424.
[3]	HUANG Chen, JING Feng, YANG Zhitao, et al . Exploration and practice of construction of nursing management system in shelter hospital [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 286-290.
[4]	LIANG Jing, HUANG Chen, JIANG Yan, et al . Management strategy of nursing for prevention and control of COVID-19 in emergency infusion room [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 281-285.
[5]	ZHANG Hong, ZHU Mengmeng, et al . Safety nursing for eating in the elderly during the COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 277-280.
[6]	ZHOU Jianping, YANG Zhenhua, WANG Yichen, et al . Practice and thinking of the medical team of the elderly medical assistance center in the prevention and control of COVID-19 in Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 265-269.
[7]	ZHA Qinghua, WANG Xiaoning, ZHANG Yin, et al . Exploration and practice of nucleic acid sampling outside hospital during the epidemic period of COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 229-233.
[8]	YU Ping, QIU Weiyu, WANG Xu, et al . Practice and exploration of drug security management in large shelter hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 221-224.
[9]	JIANG Yan, LIN Wei, HUANG Chen, et al . Exploration and practice of emergency supplies management mode in emergency department under COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 212-215.
[10]	TANG Jie, MA Longxin, CAO Qing, et al . Study on the construction of smart shelter hospital based on new generation information technology [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 196-204.
[11]	JIANG Yan, CHEN Ting, HUANG Chen, PAN Peiqian, JING Feng, et al . Construction and practice of emergency response capability training program for all staff in emergency medical ward under COVID-19：Emergency response strategy [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 189-195.
[12]	MENG Jun, JIN Peipei, CHEN Changqiang, CHEN Jiuming, FAN Zhenjia, CHEN Shikai, DAI Jing, et al . Emergency transformation experience of the laboratory department of a hospital designated for admission of patients with novel coronavirus infection in emergency conversion [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 184-188.
[13]	SHI Yingying, ZHONG Xu, LIU Jialin, HE Le, XIONG Shaoji, WENG Y, DING Chengwei, YANG Y, CHEN Weihon, QIU Liping, XIN Haiguang. Hospital infection prevention and control practices in anti-epidemic medical staff and workers during COVID-19 epidemic: investigation and countermeasures [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 178-183.
[14]	DING Ning, CHEN Shikai, MENG Jun, DAI Jing, JIN Peipei, et al . Correlation and influencing factors analysis of the cycle threshold value in detection of novel coronavirus nucleic acid(Omicron) and the negative conversion cycle in infected patients [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 169-173.
[15]	YANG Zhitao, CHEN Ying, JING Feng, XIE Zhihui, ZHANG Yibo, SHANG Hanbin, LIN Jingsheng, WU Wenjuan, GU Zhidong, BI Yufang, CHEN Erzhen. Practice and Exploration on the construction of medical affairs management system in large Fangcang hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 154-159.